Sign up to save your podcasts
Or
Share FDA Issues New Action Plan on Artificial Intelligence/Machine Learning-Based Software as a Medical Device
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Issues New Action Plan on Artificial Intelligence/Machine Learning-Based Software as a Medical Device
The Food and Drug Administration recently published a new Action Plan for how the agency will evaluate artificial intelligence and machine learning-based software when used as a medical device. On this episode of CalCurrent, digital health technology partner Eric Kintner discusses the FDA’s new Action Plan and how it may serve as a roadmap for future regulations.
View all episodes
By Snell & Wilmer
5
66 ratings
The Food and Drug Administration recently published a new Action Plan for how the agency will evaluate artificial intelligence and machine learning-based software when used as a medical device. On this episode of CalCurrent, digital health technology partner Eric Kintner discusses the FDA’s new Action Plan and how it may serve as a roadmap for future regulations.